Clinical Trial Update: Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm

View source ↗

Summary

A completed clinical trial update investigates biomarkers to distinguish benign thyroid adenomas and other thyroid neoplasms from malignant thyroid cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Adenoma
• Thyroid Cancer
• Thyroid Neoplasms

Snippet

Sponsor: Norman Eberhardt | Conditions: Cancer of the Thyroid, Neoplasms, Thyroid | Status: COMPLETED